A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE
Nuclear Medicine Review · 2024
DOI: 10.5603/nmr.101985 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nuclear Medicine Review, 2024. Verfasst von Martyna Kłosińska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. Hauptthemen laut MEDLINE: Glucagonoma, Organometallic Compounds, Octreotide, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
- Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. jkolodziej1@wim.mil.pl.
ORCID-Profile: Martyna Kłosińska, Joanna Kołodziej, Adrianna Mróz, Weronika Mądra, Grzegorz Kamiński
Zitieren
APA
Kłosińska, M., Kołodziej, J., Mróz, A., Mądra, W., & Kamiński, G. (2024). A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE. Nuclear Medicine Review. https://doi.org/10.5603/nmr.101985
Vancouver
Kłosińska M, Kołodziej J, Mróz A, Mądra W, Kamiński G. A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE. Nuclear Medicine Review. 2024. doi:10.5603/nmr.101985
BibTeX
@article{Kosiska2024,
author = {Kłosińska, Martyna and Kołodziej, Joanna and Mróz, Adrianna and Mądra, Weronika and Kamiński, Grzegorz},
title = {A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE},
journal = {Nuclear Medicine Review},
year = {2024},
doi = {10.5603/nmr.101985}
}
EUVIMED